Patents Assigned to Vertex Pharmaceuticals Incorported
  • Publication number: 20110098311
    Abstract: The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
    Type: Application
    Filed: October 22, 2010
    Publication date: April 28, 2011
    Applicant: Vertex Pharmaceuticals Incorported
    Inventors: Fredrick F. Van Goor, William Lawrence Burton